Nagendran Sukumar
CIK 0001665124
President and Head of R&DDirector
Filings
17
Latest Apr 13, 2026
Issuers covered
2
Showing
17 of 17
Page 1
Track record
10 of 10 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 10 | 30% | -15.9% | -11.5% | +10.5% | -51.9% |
| 90 days | 9 | 33% | -0.3% | -36.9% | +207.8% | -63.4% |
| 180 days | 6 | 17% | -17.8% | -35.7% | +92.2% | -59.6% |
| 365 days | 2 | 50% | +132.4% | +132.4% | +349.4% | -84.6% |
Issuers
Companies where Nagendran Sukumar has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| TSHA | Taysha Gene Therapies, Inc. | 13 | Apr 13, 2026 |
| SLDB | Solid Biosciences Inc. | 4 | Jun 13, 2025 |
All filings
17 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|